You are here: All Products  > CSPC Acquires China Rights to Verastem Cancer Drug in $45 Million Deal

CSPC Acquires China Rights to Verastem Cancer Drug in $45 Million Deal

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products